Top 3 Ways to Trade Monkeypox

May 25, 2022 www.tradewins.com Other Exciting News How Wendy Kirkland’s Income Accelerator Works We promised we’d send you this link and wanted to get it to you ASAP. The event was amazing and any delay in you seeing this powerful information could set back your financial timeline. If you have any questions about Wendy’s strategies we revealed we have set up a number for you to call. Just dial 1-800-268-8936 and we will help you with any questions and make it as easy as possible for you to get the alerts that have the significant wealth generating potential discussed in the webinar. CLICK HERE: Check out the Paycheck Payout Recording Again, even though the tips and strategies discussed here are already helping many people boost their trading accounts, they all had questions too. Just give us a ring when you watch the video and we will be glad to help you out. Recent Articles Top 3 Ways to Trade Monkeypox by Ian Cooper The Exits: Determining Risk by Lee Gettess PULSE Options Weekly Newsletter by Chris Verhaegh TradeWins Author Team     Tomorrow, you could begin doubling your account every single month starting with one letter. The letter will come from a 20-year trading professional named Ian Cooper. He says, “In 2022, following my trades you would be doubling even tripling your account some months. Let me show you how.” He will show you exactly what to do... and he’ll give you the blueprint for just $1. Get Daily Trade Alert Now About TradeWins Inside Trading Newsletter Webinars Videos Trading Strategy Options Futures Forex Day Trading Subscription Services E-Books Customer Satisfaction Survey 2020 Top 3 Ways to Trade Monkeypox by Ian Cooper These viruses are a royal pain in the backend… Now, aside from the coronavirus, moneypox is apparently making the rounds. “Doctors warned that numbers will rise significantly as the virus spreads through Europe and as far as the US, Canada and Australia. Spain now has the highest number of infections, outside places in Africa where the virus is endemic, with more than 50 known cases.” Officials are even investigating a presumptive case in South Florida. Another case popped up in Massachusetts, and another in New York City. Worse, President Biden just said, “Everybody should be concerned. We’re working on it, hard to figure out what we do.” Even the World Health Organization just warned that Europe could see a wave of infections this summer. The good news – According to the CDC, smallpox vaccines can protect people from the virus. “Past data from Africa suggests that the smallpox vaccine is at least 85% effective in preventing monkeypox,” says the agency. So, how can we potentially profit from it? Vaccine Stock No. 1 – Emergent Biosolutions (EBS) Emergent Biosolutions produces the ACAM2000 vaccine, which the US FDA describes as an active immunization against smallpox for those at higher risk. “According to the Centers for Disease Control and Prevention, since the monkeypox virus is closely related to the virus that causes smallpox, ACAM2000 can be used to prevent the spread of monkeypox,” says Barron’s. Read More   The Exits: Determining Risk by Lee Gettess The only thing wrong with having really, really good entries is that they don’t make you any money. You have to exit the trade before you can bank any cash. You have to exit well at a profit to attempt to maximize your gain. You have to exit as quickly as possible on losers so they don’t cost you too much. Money management and trade management are at least as important as any entry technique. There are several ways to handle these trades after getting into the market, and you can mix and match them as you please. That is one of the big advantages to having a methodology rather than a hard and fast system: You can tailor your trading around your personal comfort level and preferences instead of just following the way that makes the most money. Trading within your own comfort level, both psychologically and monetarily is probably the single most important criteria for success in the markets. Read More PULSE Options Weekly Newsletter by Chris Verhaegh First Things First There’s a lot of inflation out there! It’s easy to see at the gas pump. Those big numbers jump out at you as you drive around town. Somehow I think it’s going to get worse before it gets better. While we hope we don’t have to find out about $10 gasoline, the market is anxiously waiting to hear just how bad inflation is. And more importantly, the market is anxiously waiting to hear how the Federal Reserve (the “Fed”) plans to fight it. As it stands right now the market is expecting a 50 basis point (½%) increase to short-term rates at both the June 15th and July 27th FOMC Meetings. Right now the first point of indecision appears at the September 21st Meeting. As you can see by the graphic below it’s almost a coin toss whether the Fed will raise rates by just 25 basis points (¼%) or a full 50 basis points (½%). Read More   www.tradewins.com                © Copyright 2022 TradeWins.com. All rights reserved. TradeWins Publishing, 22C New Leicester Hwy, #117, Asheville, NC 28806 Email: support@iss-trading.com   |   Phone: 888-233-1431   |   Fax: 888-258-4938   PLEASE READ: Auto-trading, or any broker or advisor-directed type of trading, is not supported or endorsed by TradeWins. For additional information on auto-trading, you may visit the SEC’s website: All About Auto-Trading, TradeWins does not recommend or refer subscribers to broker-dealers. You should perform your own due diligence with respect to satisfactory broker-dealers and whether to open a brokerage account. You should always consult with your own professional advisers regarding equities and options on equities trading. 1) The information provided by the newsletters, trading, training and educational products related to various markets (collectively referred to as the “Services”) is not customized or personalized to any particular risk profile or tolerance. Nor is the information published by TradeWins Publishing (“TradeWins”) a customized or personalized recommendation to buy, sell, hold, or invest in particular financial products. The Services are intended to supplement your own research and analysis. 2) TradeWins’ Services are not a solicitation or offer to buy or sell any financial products, and the Services are not intended to provide money management advice or services. 3) Past performance is not necessarily indicative of future results. Trading and investing involve substantial risk. Trading on margin carries a high level of risk, and may not be suitable for all investors. Other than the refund policy detailed elsewhere, TradeWins does not make any guarantee or other promise as to any results that may be obtained from using the Services. No person subscribing for the Services (“Subscriber”) should make any investment decision without first consulting his or her own personal financial adviser, broker or consultant. TradeWins disclaims any and all liability in the event anything contained in the Services proves to be inaccurate, incomplete or unreliable, or results in any investment or other loss by a Subscriber. 4) You should trade or invest only “risk capital” – money you can afford to lose. Trading stocks and stock options involves high risk and you can lose the entire principal amount invested or more. 5) All investments carry risk and all trading decisions made by a person remain the responsibility of that person. There is no guarantee that systems, indicators, or trading signals will result in profits or that they will not produce losses. Subscribers should fully understand all risks associated with any kind of trading or investing before engaging in such activities. 6) Some profit examples are based on hypothetical or simulated trading. This means the trades are not actual trades and instead are hypothetical trades based on real market prices at the time the recommendation is disseminated. No actual money is invested, nor are any trades executed. Hypothetical or simulated performance is not necessarily indicative of future results. Hypothetical performance results have many inherent limitations, some of which are described below. Also, the hypothetical results do not include the costs of subscriptions, commissions, or other fees. Because the trades underlying these examples have not actually been executed, the results may understate or overstate the impact of certain market factors, such as lack of liquidity. Simulated trading services in general are also designed with the benefit of hindsight, which may not be relevant to actual trading. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. TradeWins makes no representations or warranties that any account will or is likely to achieve profits similar to those shown. 7) No representation is being made that you will achieve profits or the same results as any person providing testimonial. No representation is being made that any person providing a testimonial is likely to continue to experience profitable trading after the date on which the testimonial was provided, and in fact the person providing the testimonial may have experienced losses. 8) The author experiences are not typical. The author is an experienced investor and your results will vary depending on risk tolerance, amount of risk capital utilized, size of trading position and other factors. Certain Subscribers may modify the author methods, or modify or ignore the rules or risk parameters, and any such actions are taken entirely at the Subscriber’s own election and for the Subscriber’s own risk.

If you wish to stop receiving our emails or change your subscription options, please Manage Your Subscription
TradeWins Publishing, 528 North Country Rd., St. James, NY 11780

Share on Facebook

Share on Twitter

Share on Google+

Share on LinkedIn

Subscribe to receive free email updates: